Clinical trial
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
NCT01694186 · EyePoint Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT01694186 |
|---|---|
| Title | Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert |
| Official title | A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye |
| Acronym | FAI |
| Lead sponsor | EyePoint Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Infectious Uveitis |
| Intervention type | Drug |
| Interventions | FAI insert, Sham injection |
| Enrollment | 129 |
| Start date | Aug 2, 2013 |
| Primary completion | Mar 26, 2018 |
| Completion | Mar 26, 2018 |
| First posted | Sep 27, 2012 |
| Last update posted | Apr 2, 2021 |
| Countries | Germany, Hungary, India, Israel, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: